Fingerprint
Dive into the research topics of 'Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically